China's commerce ministry holds meeting with foreign pharmaceutical firms

Becton, Dickinson and Company
Merck & Co., Inc.
Eli Lilly and Company
Gilead Sciences, Inc.
Danaher Corporation

Becton, Dickinson and Company

BDX

0.00

Merck & Co., Inc.

MRK

0.00

Eli Lilly and Company

LLY

0.00

Gilead Sciences, Inc.

GILD

0.00

Danaher Corporation

DHR

0.00

BEIJING, May 22 (Reuters) - China's commerce ministry held a roundtable meeting with representatives from more than 50 foreign pharmaceutical companies on Friday, a ministry statement showed.

  • The companies include Sanofi SASY.PA, Novartis NOVN.S, BD BDX.N, Danaher DHR.N, Merck MRK.N, Eli Lilly LLY.N and Gilead Sciences GILD.O, according to the statement.

  • China is committed to improving pricing mechanisms and regulatory systems for the health care sector, and welcomes pharmaceutical companies from all countries to deepen their presence in the Chinese market, said Ling Ji, a vice commerce minister who chaired the meeting.


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.